Having spoken with shareholders who are much closer to management than I, it seems that once again newly appointed directors whom have recently stepped down had agendas which included getting this project into production. I was always lead to believe that would be left for somebody else and we were just to prove up a resource, complete a PFS and get this baby sold. Hopefully now IB is back directing the ship we can get on with this process. The stock is looking a little healthier today although off a very low base. The company is now operating on the smell of an oily rag. A couple of a million bucks would well and truly see them through until the end of the year by which time IB could have this sale process all wrapped up. Dilution could be limited to say 40m shares at 5c to get them through. IB did talk about converting his loans at a premium to current levels so 5c may tie in well. Pure speculation on my part but I have topped up today hoping for a multi bagger by years end from these levels.
- Forums
- ASX - By Stock
- M4M
- kfe - the next 3 months
kfe - the next 3 months, page-9
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add M4M (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.1¢ |
Change
-0.001(4.55%) |
Mkt cap ! $76.08M |
Open | High | Low | Value | Volume |
2.3¢ | 2.3¢ | 2.1¢ | $98.74K | 4.613M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 1122221 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.3¢ | 792204 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 672221 | 0.021 |
12 | 2227000 | 0.020 |
12 | 1659214 | 0.019 |
8 | 1669999 | 0.018 |
3 | 308823 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.023 | 792204 | 2 |
0.024 | 450000 | 2 |
0.025 | 563195 | 3 |
0.026 | 961538 | 1 |
0.027 | 2050245 | 3 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
M4M (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online